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he cause of Huntington’s disease is expansion of
polyglutamine (polyQ) domain in huntingtin, which
makes this protein both neurotoxic and aggregation
prone. Here we developed the ﬁrst yeast model, which
establishes a direct link between aggregation of expanded
polyQ domain and its cytotoxicity. Our data indicated that
deﬁciencies in molecular chaperones Sis1 and Hsp104
inhibited seeding of polyQ aggregates, whereas 
 
ssa1
 
, 
 
ssa2
 
,
and 
 
ydj1–151
 
 mutations inhibited expansion of aggregates.
The latter three mutants strongly suppressed the polyQ
toxicity. Spontaneous mutants with suppressed aggregation
appeared with high frequency, and in all of them the toxicity
was relieved. Aggregation defects in these mutants and in
T
 
sis1–85 
 
were not complemented in the cross to the 
 
hsp104
 
mutant, demonstrating an unusual type of inheritance.
Since Hsp104 is required for prion maintenance in yeast,
this suggested a role for prions in polyQ aggregation and
toxicity. We screened a set of deletions of nonessential
genes coding for known prions and related proteins and
found that deletion of the 
 
RNQ1
 
 gene speciﬁcally suppressed
aggregation and toxicity of polyQ. Curing of the prion form
of Rnq1 from wild-type cells dramatically suppressed both
aggregation and toxicity of polyQ. We concluded that aggre-
gation of polyQ is critical for its toxicity and that Rnq1 in
its prion conformation plays an essential role in polyQ aggre-
gation leading to the toxicity.
 
Introduction
 
Expansion of polyglutamine (polyQ) domains in certain
proteins causes several fatal neurodegenerative diseases, for
example, Huntington’s disease. All of these diseases are in-
herited as a dominant trait, and their onset and severity
closely correlate with the length of abnormal polyQ sequences
(Gusella and Macdonald, 1998; Cummings et al., 1999a).
These and other observations led to a conclusion that polyQ
expansion is a gain-of-function mutation, causing polypep-
tides with expanded polyQ (for example, huntingtin) to
acquire an unusual conformation, which facilitates their
aggregation into intracellular inclusion bodies (IBs)* and
causes cell toxicity (Difiglia et al., 1997; Scherzinger et al.,
1997; Bates et al., 1998).
It was initially assumed that denatured or abnormal proteins
aggregate and form IBs simply due to their intrinsic ten-
dency to associate with each other until the aggregates
eventually become insoluble. However, recent reports
demonstrated that formation of cytoplasmic IBs in mam-
malian cells may be a complex process involving transport
of small protein aggregates from the cell’s periphery to the
centrosome along microtubules. These IBs contain Hsps,
ubiquitin, ubiquitin-conjugating enzymes, and 26S protea-
somes forming a large structure termed aggresome (Vidair
et al., 1996; Wojcik et al., 1996; Johnston et al., 1998; Anton
et al., 1999; Garcia-Mata et al., 1999; Wigley et al., 1999;
Fabunmi et al., 2000). Recent findings from our and other
groups indicate that IBs formed by polyQ-containing
polypeptides have similarities with the aggresome (Ste-
noien et al., 1999; Wyttenbach et al., 2000; Meriin et al.,
2001; Waelter et al., 2001). Furthermore, we have found
recently that a stress-activated protein kinase MEKK1
stimulates early stages of IB formation (Meriin et al.,
2001), suggesting that various steps of IB formation are
tightly controlled by the cell.
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Close correlation between formation of the huntingtin-
containing IBs and death of the affected neurons suggests
that IB may be involved in neurodegeneration (Davies et al.,
1998). However, there is evidence that IB formation may
not be necessary for the neuronal death, since artificial inhi-
bition of aggregation of polyQ-containing polypeptides in
certain animal and cellular models did not inhibit and even
enhanced neuronal apoptosis (Klement et al., 1998; Saudou
et al., 1998; Cummings et al., 1999b). Therefore, IB forma-
tion may be irrelevant to the neurodegeneration process or
may even serve a protective role by capturing toxic soluble
polyQ molecules (for review see Sherman and Goldberg,
2001). The question whether soluble abnormal proteins or
IBs cause toxicity and neurodegeneration is the focus of on-
going discussion in the field. Because of the complexity of
polyQ-induced neuronal death and IB formation, develop-
ment of adequate cellular and animal models is critical to
dissect cellular mechanisms of these processes. The practical
application of this research would be identification of pro-
teins involved in neurodegeneration and IB formation in or-
der to use them as targets for drug design.
In mice, 
 
Drosophila
 
 and 
 
Caenorhabditis elegans
 
 expression
of extended polyQ polypeptides caused toxicity and neuro-
degeneration, and IBs in neurons were detectable, whereas
polypeptides with polyQ of normal length were not toxic
and did not form IBs (Davies et al., 1997; Scherzinger et al.,
1997; Kazemi-Esfarjani and Benzer, 2000; Satyal et al.,
2000). Notably, in mice model expression of exon 1 of
huntingtin, a small NH
 
2
 
-terminal fragment with extended
polyQ domain, was sufficient to cause both neurodegenera-
tion and IB formation (Davies et al., 1997). Yeast 
 
Saccharo-
myces cerevisiae
 
 has also been used as a model, since it pro-
vides a useful tool for screening of genes involved in IB
formation and potential polyQ-induced toxicity and for
screening of chemical compounds, which inhibit these pro-
cesses. Short polyQ was shown to be soluble in yeast,
whereas long polyQ polypeptide–formed IBs; however, no
toxicity of polyQ polypeptides in yeast has been reported so
far (Krobitsch and Lindquist, 2000; Muchowski et al.,
2000). In these yeast models, the molecular chaperone
Hsp104 was reported to be essential for the aggregation of
polyQ (Krobitsch and Lindquist, 2000). Overexpression of
other molecular chaperones Hsp70 and Hdj1 also affected
polyQ aggregation suppressing formation of fibrous aggre-
gates and promoting instead formation of amorphous struc-
tures (Muchowski et al., 2000).
The molecular chaperones Hsp104, Hsp70, and Sis1 were
implicated in emergence and maintenance of prion conforma-
tion of certain yeast proteins, for example, Sup35, Rnq1,
Ure2 (Chernoff et al., 1995, 1999; Derkatch et al., 1997;
Newnam et al., 1999; Jung et al., 2000; Moriyama et al.,
2000; Sondheimer and Lindquist, 2000; Sondheimer et al.,
2001; Wegrzyn et al., 2001). These polypeptides in prion
conformation aggregate and convert normal polypeptides of
the same type into prion conformation, thus recruiting them
into IBs. The phenotypic traits resulting from such aggrega-
tion are inherited in a non-Mendelian fashion (Wickner et al.,
1999; Serio and Lindquist, 2000). These mechanisms closely
resemble aggregation of mammalian prion PrP, a cause of a
group of neurodegenerative disorders (Prusiner, 2001).
Here, we develop a new yeast model of polyQ expansion dis-
eases, which establishes a direct link between polyQ aggrega-
tion and toxicity. Using this model we searched for cellular ele-
ments involved in control of polyQ aggregation and toxicity.
 
Results
 
Accumulation of 103Q is toxic to yeast cells
 
To develop the yeast model of the polyQ expansion disease,
we expressed in yeast cells the green fluorescent protein
(GFP)–tagged polypeptides derived from normal (25Q) and
mutant (103Q) (see Materials and methods) forms of hun-
tingtin under a galactose-inducible promoter. In contrast to
25Q, expression of 103Q was toxic to yeast cells, since colonies
expressing 103Q ceased to grow within 1–2 d after induction
on galactose medium (Fig. 1 A, top). No difference in colony
size was seen on glucose-containing medium without polyQ
expression (Fig. 1 A, bottom), indicating that accumulation
of 103Q was responsible for the growth defect.
Notably, the cellular levels of accumulated 103Q were
much lower than the level of 25Q as seen by a decrease in in-
Figure 1. Accumulation of 103Q in yeast cells inhibits yeast 
growth. (A) Cells transformed with 25Q or 103Q expression vector 
grew on selective glucose plates for 3 d or on galactose plates for 
5 d. (B) Flow cytometry analysis of fluorescence of the cells induced 
for 20 h. The peaks at the left represent cells, which do not express 
polyQ. Note, the scale of the fluorescence of accumulated GFP 
fusion is logarithmic. (C) Accumulation of 103Q does not affect cell 
cycle. FACS
® analysis of yeast cultures expressing 25Q or 103Q 
after 20 h induction in selective galactose medium. 
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tensity of fluorescence of the cells expressing 103Q (Fig. 1
B). This difference in accumulation of the polyQ polypep-
tides evidently was not related to 103Q degradation, since
both 25Q and 103Q polypeptides were relatively stable in
yeast (unpublished data). The difference in expression may
be related to reduction of the plasmid copy number in cells
expressing 103Q due to plasmid instability. Accordingly, in
spite of constantly maintained selection for the plasmid’s
URA marker cells expressing 103Q were losing this plasmid
rapidly. After 3 d on selective galactose plate, only 0.1% of
cells expressing 103Q retained the plasmid with the 103Q
gene, whereas as much as 25% of cells expressing 25Q still
maintained the plasmid (unpublished data). Therefore, the
103Q-induced toxicity appears to be so severe that cells
which lost the plasmid have an advantage over 103Q-express-
ing cells even on the selective medium.
To study whether expression of expanded polyQ inhibits
growth by affecting the cell cycle progression, we compared
cellular DNA contents in the cultures expressing 25Q and
103Q. Cells induced in selective galactose medium for 20 h
were stained with propidium iodide and then analyzed by
FACS
 
®
 
. Expression of 103Q in strain W303 caused a slight
increase of G2 phase cells in comparison with cells expressing
25Q (unpublished data), whereas in 103Q-expressing JN54
cells no changes in the cell cycle were observed (Fig. 1 C) in
spite of significantly decreased growth. This indicates that
there is no substantial cell cycle delay, which could account
for the growth inhibition upon accumulation of 103Q.
 
Molecular chaperones are essential 
for polyQ aggregation and toxicity
 
Microscopic observation showed that 25Q was diffusely dis-
tributed in yeast cells, whereas every cell expressing 103Q
formed multiple aggregates of two types (Fig. 2 A): appearing
either as large disordered lumps or as small grains (or flakes),
some of which were swarming in a cell. A fraction of cells
with small aggregates increased in expense of cells with large
aggregates upon prolonged 103Q accumulation, suggesting
that aggregates are dynamic formations capable of further
evolution. Fractionation of cell homogenates in the presence
of 1% Triton X-100 provided independent evidence that the
majority of 25Q (
 
 
 
75%) were soluble in the cells (Fig. 2 B).
Notably, a fraction of the 25Q was found in 800 g pellets, in-
dicating that although visible aggregates were not seen with
short polyQ, some of the molecules associated with large de-
tergent-insoluble cellular structures. With 103Q, from 50 up
to 95% of the polypeptide was found in pellets, depending
on duration of induction and yeast strain.
Because polyQ expression in yeast shows a length-depen-
dent toxicity, this system offers a simple method to study the
mechanisms of polyQ aggregation and toxicity genetically.
In search of cellular elements controlling the process of ag-
gregation, we screened a set of mutants of chaperones and
related proteins, including 
 
hsp104
 
, 
 
ssa1 ssa2
 
, 
 
ssa1 ssa3
 
, 
 
ssa1
ssa4
 
, 
 
ssb1 ssb2
 
, 
 
sse1
 
, 
 
sse2
 
,
 
 pdr
 
,
 
 ydj1–151
 
,
 
 sis1–85
 
, 
 
xdj1
 
,
 
 zuo1
 
,
 
ypr061c
 
,
 
 ynl227c
 
,
 
 yfr041c
 
,
 
 ynl077w
 
, 
 
sti1
 
,
 
 
 
and 
 
sba1
 
. Among
these mutants, 
 
hsp104
 
 deletion, 
 
sis1–85
 
 mutation, 
 
ssa1 ssa2
 
double deletion (Fig. 2 C) and 
 
ydj1–151
 
 mutation (unpub-
lished data) significantly suppressed 103Q aggregation as as-
sayed by fractionation. Two distinct types of the aggregation
patterns were seen with these chaperone mutants. In 
 
ssa1
ssa2
 
 (Fig. 2 D) and 
 
ydj1–151
 
 (unpublished data) mutants,
103Q formed a multitude of very small grain-like aggregates
against a bright diffused background representing soluble
103Q. (Of note, there was no compensatory induction of
other chaperones in this particular strain of 
 
ssa1 ssa2
 
 mu-
tant.) In 
 
hsp104
 
 and 
 
sis1–85
 
 strains, the majority of cells did
not form any visible aggregates, and the rest of the cells
formed one or few large condensed aggregates (Fig. 2 D).
These large aggregates resembled a compressed bundle of fil-
aments, whose appearance was completely different from the
IBs seen in the wild-type strain (compare Fig. 2 A).
The differences in 103Q aggregation patterns in the chap-
erone mutants may reflect different roles of the chaperones
in polyQ aggregation. We followed the process of aggrega-
tion in wild-type and mutant cells in real time by taking pic-
tures every 2 min of several selected cells expressing 103Q.
In the wild-type, initially all fluorescent cells contained small
aggregates. With time, intensity of fluorescence in aggregates
and aggregate size grew, whereas the soluble (diffusely dis-
tributed) fluorescent material gradually disappeared (Fig. 3).
However, even after 60 min of observation a certain pool of
Figure 2. Molecular chaperones are involved in aggregation of 
103Q in yeast cells. (A) Fluorescent confocal micrographs of yeast 
cells expressing polyQ polypeptides after induction for 7 h. 
(B and C) Levels of polyQ polypeptides (20 h induction) in soluble 
and insoluble fractions of yeast cells lysates. Sup, soluble fraction; 
Pel, pellets. (D) Confocal micrographs of yeast strains expressing 
103Q. ssa1, 2 and sis1–85 mutants (top); hsp104 deletion mutant 
(bottom). (The picture with combined fluorescent and phase–contrast 
microscopy on the right makes cells with one large aggregate and 
no diffused fluorescence visible.) 
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103Q still remained soluble. Unlike the wild-type cells, in
 
ssa1 ssa2
 
 cells no apparent redistribution of soluble 103Q
into numerous aggregates was seen within 60 min (unpub-
lished data), indicating that although the nucleation of ag-
gregates is unimpeded in this mutant, further growth of the
aggregates is inhibited. We monitored rare events of IB for-
mation in the 
 
hsp104
 
 mutant and found a remarkable differ-
ence with polyQ aggregation compared with the wild-type
cells (Fig. 3). Once started, the aggregation of 103Q in
 
hsp104
 
 mutant proceeded rapidly, so 6–12 min after the first
appearance of visible seeds almost all soluble polyQ in the
cell collapsed into them, forming large IBs (Fig. 3). There-
fore, the rate-limiting step in the 
 
hsp104
 
 mutant is not
growth of prenucleated aggregates but initiation of the ag-
gregation process. In a small number of cells where aggre-
gates are seeded despite the lack of Hsp104, the consequent
growth of the IB proceeds rapidly. Therefore, Hsp104 ap-
pears to be involved (possibly indirectly as discussed below)
in nucleation of polyQ aggregates, whereas members of the
Ssa family appear to be involved in expansion of prenucle-
ated aggregates, which defines the difference in aggregation
phenotypes in the chaperone mutants.
Most importantly, suppression of aggregation in the
 
hsp104
 
, 
 
ssa1 ssa2
 
, and 
 
ydj1–151
 
 chaperone mutants, inde-
pendently on the mechanism, correlated with suppression of
polyQ toxicity. The 
 
ssa1ssa2
 
 and 
 
ydj1–151
 
 mutants grew
slower than the parental strain as seen with control cells ex-
pressing 25Q. By contrast, expression of 103Q, although
dramatically reducing growth of wild-type colonies, did not
significantly affect growth of these mutants (Fig. 4, bottom).
It was difficult to make a conclusion about the effect of 
 
sis1–
85
 
 mutation on polyQ toxicity, since 
 
SIS1
 
 is an essential
gene, and this mutation by itself dramatically slowed growth
of yeast. The 
 
hsp104
 
 deletion, which did not affect yeast
growth (unpublished data), relieved 103Q toxicity (Fig. 4,
top), so colonies of cells lacking Hsp104 transformed with
either 103Q or 25Q were large and did not differ in size on
galactose plate (unpublished data). We studied whether re-
lief of polyQ toxicity in the 
 
hsp104
 
 mutant was caused by
suppression of aggregation. Since 103Q aggregated in a frac-
tion of 
 
hsp104
 
 cells, we investigated whether in these cells
aggregation was toxic. Accordingly, individual cells of the
 
hsp104
 
 strain induced in the galactose medium for 16 h were
placed on a grid on galactose-selective plates using a micro-
manipulator. Cells containing IBs were identified, and
emergence of colonies was monitored. Although 14 out of
18 cells without aggregates gave rise to colonies, only 1 out
of 9 cells with aggregates formed a colony, suggesting that
even for 
 
hsp104
 
 mutant cells IBs are toxic. These data indi-
cate that the growth defect in yeast cells expressing expanded
polyQ is caused by its aggregation.
 
Yeast prions are required for 103Q aggregation
 
To find additional cellular components involved in polyQ
aggregation and toxicity, we selected spontaneous mutants
in which aggregation of 103Q was suppressed. We expected
that 103Q would not be toxic in the cells defective in aggre-
gation; hence, the block on the polyQ expression (assayed as
cell fluorescence) would be relieved. Accordingly, using a
cell sorter we isolated a fraction of cells with the highest flu-
orescence, which was expected to be enriched with the ag-
gregation mutants. Two consequent cycles of cell sorting
yielded 
 
 
 
85% of cells without visible aggregates, indicating
that the enhanced fluorescence indeed was associated with
the reduced aggregation. The calculated frequency of the
spontaneous mutations was unexpectedly high (close to
Figure 3. Deletion in hsp104 does not impede growth of 
preformed IBs. Fluorescent images of wild-type and mutant cells 
with 103Q (expressed for 3 h before the start of the observation) 
taken at different time points. The IB formation in the mutant cell 
was recorded five times; the typical recording is presented. Figure 4. Deprivation of yeast cells of certain chaperones 
relieves 103Q-associated toxicity. Growth (4 d) of hsp104 mutant 
and the corresponding wild type (top), both expressing 103Q and 
ssa1,ssa2 mutant and the corresponding wild type (bottom) 
expressing 103Q or 25Q. 
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10
 
 
 
3
 
). The aggregation pattern in 25 randomly chosen inde-
pendent clones resembled that of 
 
hsp104
 
 and 
 
sis1–85
 
 mu-
tants (Fig. 5 A, top). Importantly, in all of these clones
103Q-associated growth defect was suppressed (unpublished
data), emphasizing the correlation between aggregation of
polyQ and its toxicity.
Mating of all 25 spontaneous mutants and 
 
hsp104
 
 and
 
sis1–85
 
 mutants with the wild-type haploid strain (BY4742)
demonstrated that the aggregation defects were recessive (un-
published data). Surprisingly, all diploids obtained by mat-
ing the spontaneous mutants with the 
 
hsp104
 
 deletion strain
displayed defects in aggregation similar to that of parental
mutants (unpublished data), indicating the lack of comple-
mentation. Since a frequency of spontaneous mutations of
10
 
 
 
3
 
 in the 
 
hsp104
 
 gene is improbable, these data implied an
unusual type of inheritance. Crossing of the 
 
hsp104
 
 deletion
mutant with 
 
sis1–85
 
 also yielded diploid cells with defects in
aggregation similar to that of parental mutants (unpublished
data), indicating that defects in polyQ aggregation were in-
herited in a non-Mendelian manner.
The conclusive proof of such type of inheritance came
from sporulation/dissection of diploids resulting from mating
of the mutants with the wild-type strain. All four spores in a
tetrad usually displayed wild-type–like aggregation and toxic-
ity of 103Q, indicating a non-Mendelian mode of inherit-
ance. In contrast, sporulation and dissection of diploids orig-
inating from a mating of wild-type strain and 
 
hsp104
 
 mutant
resulted in 2:2 segregation of aggregation/toxicity pattern. In
these tetrads, suppressed aggregation was always associated
with the 
 
hsp104
 
 deletion. The non-Mendelian mode of in-
heritance of polyQ and toxicity was reminiscent of inherit-
ance of prion elements in yeast (Wickner et al., 1999; Sond-
heimer and Lindquist, 2000). Since both Hsp104 and Sis1
have been implicated in prion propagation (Chernoff et al.,
1995; Derkatch et al., 1997; Moriyama et al., 2000; Sond-
heimer and Lindquist, 2000; Sondheimer et al., 2001), we
suggested that some protein(s) in prion conformation may be
essential for toxicity and aggregation of polyQ polypeptides.
To test this possibility, we screened a set of deletion muta-
tions in nonessential prion genes and in genes involved in ag-
gregation of prion proteins (i.e., 
 
mks1
 
,
 
 new1
 
,
 
 sla1
 
,
 
 rnq1
 
,
 
 ure2
 
,
and 
 
ybr016w
 
) for their effects on polyQ aggregation. Of all of
the mutants tested, only cells with the 
 
rnq1
 
 deletion displayed
an aggregation defect. The 103Q aggregation pattern in these
cells was similar to that of 
 
hsp104
 
 and 
 
sis1–85
 
 mutants (Fig. 5
A, middle). No 103Q-related toxicity was detected in 
 
rnq1
 
mutant cells (Fig. 5 B) despite the fact that 103Q was accu-
mulated to higher levels than in the wild-type strain (Fig. 5
C). Mating of the 
 
rnq1
 
 mutant with the isogenic wild-type
strain followed by sporulation and tetrad dissection resulted
in a 2:2 segregation of suppressed aggregation to toxicity as
was shown before with the 
 
hsp104
 
 mutant. Suppressed aggre-
gation was always associated with 
 
rnq1
 
 deletion. These data
strongly indicate that Rnq1 is essential for aggregation and
toxicity of polyQ polypeptides in yeast. Using a differential
centrifugation of cell homogenates, we found that in W303
and JN54, the wild-type strains used in this study, all Rnq1
protein was associated with 100,000 g pellets, indicating that
this protein exists in prion form (Fig. 5 D).
To investigate whether prion conformation of Rnq1 is
critical for polyQ aggregation, we employed a method of
curing yeast cells of prions by growing them in the presence
of guanidine hydrochloride (GuHCl), which prevents prop-
agation of prion conformation (for review see Chernoff,
2001). Accordingly, yeast cells were grown for three passages
on glucose-containing medium (to block 103Q induction)
Figure 5. 103Q aggregation and toxicity depend on yeast prions. 
(A) Fluorescent confocal micrographs of yeast strains expressing 103Q. 
(B) Growth (4 d) of wild-type, guanidine-pretreated and rnq1mutant 
cells expressing103Q. (C) Increase in the cellular levels and solubility 
of 103Q (expressed for 24 h) in the cells presented in Fig. 5 B; Gua, 
GuHCl pretreated; rnq, rnq1 mutant. Note that (a) 103Q is represented 
by the lowest band and (b) most of insoluble 103Q in GuHCl-treated 
and rnq1 cells represents the polypeptide from the fraction of cells with 
IBs. (D) Distribution of Rnq1 between supernatant (S) and pellet (P) 
after a centrifugation at 100,000 g of homogenates of the original 
W303 and JN54 strains and their derivatives.1002 The Journal of Cell Biology | Volume 157, Number 6, 2002
in the presence of 5 mM GuHCl. Expression of 103Q was
induced in 22 randomly chosen individual clones originat-
ing from this procedure, and 21 of them displayed the aggre-
gation phenotype similar to that of the spontaneous mutants
described above (Fig. 5 A, bottom). Moreover, none of the
21 clones demonstrated a growth defect in response to accu-
mulation of 103Q (Fig. 5 B) despite 103Q levels being sig-
nificantly higher than the levels in the original cells (Fig. 5
C), which underscores the importance of polyQ aggregation
for its toxicity. In two randomly chosen clones with no
polyQ aggregation, all Rnq1 was found in the 100,000 g su-
pernatant fraction in contrast to the original strain where
most of Rnq1 was found in the insoluble fraction (Fig. 5 D).
This confirms that the GuHCl treatment indeed cured cells
of prion form of Rnq1 ([RNQ
 ]). These data strongly sug-
gest that prion conformation of Rnq1 is essential for aggre-
gation and toxicity of polyQ.
Since hsp104 and sis1 mutations are known to cure cells of
[RNQ
 ] (Derkatch et al., 1997; Sondheimer et al., 2001), it
appears that suppression of polyQ aggregation and toxicity
by these mutations is caused primarily by the loss of Rnq1
prion. On the other hand, the ssa1ssa2 and ydj1–151 muta-
tions, which also relieved polyQ-related toxicity (Fig. 4), did
not affect prion state of Rnq1, since all Rnq1 remain associ-
ated with the insoluble fraction in the ssa1ssa2 or ydj1–151
cells homogenates (Fig. 5 D). Therefore, effects of ssa1ssa2
and ydj1–151 mutations appear to be unrelated to [RNQ
 ].
These data support the notion that Ssa and Ydj1 apparently
affect a step in IB formation different from one controlled
by Hsp104 and Sis1.
Discussion
Here, we describe the first yeast model of polyQ expansion
diseases in which accumulation of the polyQ domain was cy-
totoxic. The fact that 103Q is toxic for yeast cells may imply
that the deleterious effects of polyQ extension are more gen-
eral than they appeared before and that the mechanisms of
toxicity could be conserved through evolution. The novel
yeast model sheds light on the debated connection between
aggregation of polyQ and its toxicity. We present several lines
of evidence that the toxicity strongly associates with polyQ ag-
gregation: (a) short polyglutamine, which did not form aggre-
gates, was not toxic for the cells in spite of being accumulated
at higher levels, whereas long polyglutamine aggregated and
was toxic; (b) impairment of aggregation at apparently two
distinct steps in chaperone mutants hsp104 and ssa1ssa2 or
ydj1–151 led to suppression of 103Q toxicity, whereas in the
rare hsp104 mutant cells, which formed IBs, 103Q remained
toxic; (c) deletion of the RNQ1 gene encoding a prion protein
suppressed both aggregation and toxicity; and (d) curing the
wild-type cells of prions suppressed 103Q aggregation and
was sufficient to relieve the cytotoxicity in the course of subse-
quent 103Q induction. The most plausible conclusion from
these data is that 103Q aggregation is essential for its toxicity.
Our data indicate that in addition to genetic factors the
presence of prions determines polyQ aggregation and conse-
quently cytotoxicity in yeast cells. It is possible that the lack
of polyQ toxicity in previously reported yeast models may be
related to the lack of [RNQ
 ] prion in the strains used in
those experiments (Krobitsch and Lindquist, 2000; Hughes
et al., 2001). This suggestion is supported by the morphol-
ogy of aggregates in these reports, which resembled that in
our clones cured of [RNQ
 ] prion. Another critical factor in
toxicity appears to be the intracellular level of expanded
polyQ (unpublished data).
Our data demonstrate that, counterintuitively and in con-
trast to in vitro results, aggregation of polyQ in vivo is
strongly dependent on cellular factors. We found that
among chaperones, in addition to Hsp104 (Krobitsch and
Lindquist, 2000), Sis1, Ssa1/2, and Ydj1 also play an essen-
tial role in formation of the IBs. The majority of cells mu-
tated in either hsp104 or sis1 genes were unable to form any
visible 103Q aggregates. In rare hsp104 mutant cells in
which nucleation of aggregates occurred, IBs grew effi-
ciently. These data suggest that Hsp104 (and probably Sis1)
is not essential for expansion of aggregates but rather for
seeding of IBs. Likely, these chaperones control seeding of
aggregates via maintenance of the [RNQ
 ] prion (Derkatch
et al., 1997; Sondheimer et al., 2001; Wegrzyn et al., 2001).
In addition, Hsp104 could be directly involved in shearing
of polyQ aggregates. Such a role for Hsp104 would be con-
sistent with its involvement in shearing of Sup35 aggregates
(Patino et al., 1996; Paushkin et al., 1996), which is critical
for maintenance of prion form of Sup35 ([PSI
 ]) (for review
see Chernoff, 2001; Wegrzyn et al., 2001).
Ssa1/Ssa2 and Ydj1 were also essential for formation of
IBs but at a different step. Real-time observation of this
process indicated that Ssa1/Ssa2 (possibly with the help of
Ydj1) might be involved in expansion of preformed seeds.
This agrees with the previously proposed role of Ssa in the
growth of prion aggregates in yeast (for review see Cher-
noff, 2001). In cells with decreased levels of Ssa (or de-
prived of Ydj1), growth of aggregates might become a limit-
ing step, and some 103Q molecules unable to join IBs
would remain soluble, which in turn would allow more nu-
cleation centers to emerge in a cell and a much higher num-
ber of small aggregates to be formed. Together these data
indicate a novel and unexpected role of molecular chaper-
ones in promoting formation of protein aggregates. Fur-
thermore, different chaperones facilitate two distinct steps
in the aggregation process. Interestingly, although physio-
logical levels of chaperones are necessary for the aggrega-
tion, overexpression of Hsp104, Hsp70, and Hsp40 was re-
ported to keep polyQ polypeptides in a soluble form (Chan
et al., 2000; Satyal et al., 2000). However, it should be
noted that it is not clear whether strains used in these stud-
ies contained the [RNQ
 ] prion.
Our data that the polypeptide with expanded polyQ
forms inclusions only in the presence of the [RNQ
 ] prion
are consistent with the latest report showing that aggregation
of the MJD protein with polyQ expansion is facilitated in
so-called [PIN
 ] cells. [PIN
 ] is a non-Mendelian genetic
trait promoting emergence of [PSI
 ] (Derkatch et al.,
1997). It was shown that [PIN
 ] may be caused by a num-
ber of potential prion-forming proteins, for example, Rnq1
and New1 (Derkatch et al., 2001). Interestingly, deletion of
the NEW1 gene did not significantly affect aggregation of
103Q polypeptide, suggesting the major role of [RNQ
 ]
prion in this process. Whether aggregates of prion form ofPolyglutamine aggregation and toxicity in yeast | Meriin et al. 1003
Rnq1, which has a QN-rich domain, could directly serve as
a nucleation site for polyQ, or Rnq1 acts on the polyQ ag-
gregation indirectly is yet to be established.
Our data show that the toxicity of expanded polyQ
polypeptide in yeast cells depends on the presence of prion
in a cell. This fact suggests that in mammalian tissues some
(possibly other than PrP) prion-like proteins may be re-
quired for aggregation and neuronal pathology of mutant
polypeptides with expansion of the polyglutamine tract.
This consideration establishes a link between the two seem-
ingly distant groups of neurodegenerative diseases.
Presented here is a yeast model of cytotoxicity caused by
polyQ aggregation, which can be further used in a search for
yeast genetic modifiers of aggregation and viability. The
identification of such cellular factors will ultimately facilitate
the quest for genetic modifiers in humans and be crucial for
understanding the mechanisms of the development of
polyQ expansion-related pathology.
Materials and methods
Strains and plasmids
Deletion mutants of the S. cerevisiae wild-type strains BY4739 (MAT  leu2 
lys2  ura3 ) and BY4742 (MAT  his3  leu2  lys2  ura3 ) were obtained
from the deletion library  (ResGen; Invitrogen) of yeast nonessential genes
(Winzeler et al., 1999). Table I lists all other strains used in this work.
Vectors for expression of polyQ constructs under control of Gal1 pro-
moter were a gift from A. Kazantsev (Massachusetts Institute of Tech-
nology). DNA constructs for mammalian expression of huntingtin with
alternating CAG/CAA repeats of different length have been described pre-
viously (Kazantsev et al., 1999). Exon1 sequences containing the first
17 amino acids followed by 25 or 103 glutamines were fused in frame
with a GFP tag at the COOH terminus of each construct, and a FLAG tag
was attached to their NH2 termini (resulting in 25Q or 103Q). Such con-
structs were subcloned into the pYES2 vector (Invitrogen).
Observation of yeast growth and induction
Cells were routinely grown at 30 C on selective SD medium and then
transferred into SG liquid or solid medium for induction of 25Q or 103Q
expression.
To stain cells with propidium iodide for flow cytometry, 0.5–5 ml of
cells grown in SG medium overnight were harvested, washed with 50 mM
Tris-HCl (pH 7.5), and treated as follows. Cells were fixed in 70% ethanol
for 1 h, washed, and treated with 1 mg/ml RNase A in 50 mM Tris-HCl (pH
7.5) for 1 h with rotation. Then, cells were treated with 0.5% pepsin in 55
mM HCl for 5 min and incubated with 0.05 mg/ml propidium iodide in
180 mM Tris-HCl, pH 7.5, 200 mM NaCl, and 7 mM MgCl2 overnight at
4 C with rotation.
Microscopy
Confocal microscopy was performed with laser scanning system Radiance
2000 (Bio-Rad Laboratories). To follow a process of aggregation in real
time, 103Q was induced for 3 h, cells were harvested, mounted on glass
slides covered with solid (1.5% agarose) galactose medium, and observed
under the deconvolution epifluorescent microscope (Deltavision; Applied
Precision, Inc.). Every 2 min, 10–15 serial sections (0.25 mm/section, 0.5 s
exposure/section) were taken to cover the whole thickness of the cell for a
total of 1 h.
Analysis of solubility of polyQ polypeptides and Rnq1 
protein in cell lysates
Collected cells were disrupted by vortexing with 425–600  m acid-
washed glass beads in 40 mM Hepes, pH 7.5, 50 mM KCl, 1% Triton
X-100, 2 mM DTT, 1 mM Na3VO4, 50 mM  -glycerophosphate, 50 mM NaF,
5 mM EDTA, 5 mM EGTA, 1 mM PMSF, 1 mM benzamidine, and 5  g/ml
each of leupeptin, pepstatin A, and aprotinin. Disintegration by lyticase
treatment provided similar results (unpublished data). After disintegration,
cell lysates were left in narrow tubes for 1 h to allow  95% of unbroken
cells to sediment by the gravity force, whereas almost all of the aggregates
released from the broken cells stayed in the solution (unpublished data).
The upper portion of supernatant was carefully removed and used for frac-
tionation. Samples were normalized by the amount of total protein. Lysates
were subjected to centrifugation at 800 g for 10 min. The pellets were
washed once with the lysis buffer and resuspended in a volume of water
equal to the volume of the supernatant. To assess intracellular aggregation
of Rnq1, cells were disrupted by vortexing with glass beads in the buffer
containing 50 mM Tris-HCl, pH 8.0, 10 mM KCl, 100 mM EDTA, 1 mM
DTT, 1.0% Triton X-100, and 0.2% SDS. Then cell homogenate was
cleared from debris by 10 min centrifugation at 3,000 g and subjected to
centrifugation at 100,000 g to separate soluble and insoluble forms of the
protein. All samples were supplemented with loading SDS-PAGE buffer
containing 2% SDS and boiled for 3 min before being subjected to immu-
noblotting. GFP-tagged polyQ polypeptides were visualized with anti-GFP
antibody (polyclonal) (CLONTECH Laboratories, Inc.). Rnq1 antibody was
a gift from S. Lindquist (Whitehead Institute, Cambridge, MA).
This work was supported by National Institutes of Health and Hereditary
Disease Foundation grants to M.Y. Sherman, a National Institutes of Health
grant (R01GM58763) to Y.O. Chernoff, and the ALS Association.
Submitted: 20 December 2001
Revised: 1 April 2002
Accepted: 17 April 2002
References
Anton, L.C., U. Schubert, I. Bacik, M.F. Princiotta, P.A. Wearsch, J. Gibbs, P.M.
Day, C. Realini, M.C. Rechsteiner, J.R. Bennink, and J.W. Yewdell. 1999.
Intracellular localization of proteasomal degradation of a viral antigen. J. Cell
Biol. 146:113–124.
Bates, G.P., L. Mangiarini, and S.W. Davies. 1998. Transgenic mice in the study
of polyglutamine repeat expansion diseases. Brain Pathol. 8:699–714.
Chan, H.Y., J.M. Warrick, G.L. Gray-Board, H.L. Paulson, and N.M. Bonini.
2000. Mechanisms of chaperone suppression of polyglutamine disease: selec-
tivity, synergy and modulation of protein solubility in Drosophila. Hum.
Mol. Genet. 9:2811–2820.
Chernoff, Y.O. 2001. Mutation processes at the protein level: is Lamarck back?
Mutat. Res. 488:39–64.
Chernoff, Y.O., S.L. Lindquist, B. Ono, S.G. Inge-Vechtomov, and S.W. Lieb-
man. 1995. Role of the chaperone protein Hsp104 in propagation of the
yeast prion-like factor. Science. 268:880–884.
Chernoff, Y.O., G.P. Newnam, J. Kumar, K. Allen, and A.D. Zink. 1999. Evi-
Table I. Strains used
Strain  Genotype
W303 MATa ade2-1 trp1-1 leu2-3,112 his 3-11,15 ura3-52 can1-100 ssd1-d
hsp104  (YS483) Isogenic to W303, hsp104::LEU2
ydj1-151 (ACY17b) Isogenic to W3031b (W303 used as a wild type), ydj1-2::HIS3 LEU2::ydj1-151
WT SIS1 (CY736) Isogenic to W303, sis1 ::HIS3 (SIS1 on LEU2/CEN plasmid)
sis1-85 (CY732)  Isogenic to W303, sis1 ::HIS3 (NH
2–HA-tagged sis1-85 on LEU2/CEN plasmid)
JN54 MATa leu2-3,112 trp1  his3-11,15 ura3-52 lys2
ssa1 ssa2 (MW123) MAT  leu2-3,112 trp1  his3-11,15 ura3-52 lys2 ssa1::HIS3 ssa2::LEU2
ssa1 ssa3 (MW328) MAT  leu2-3,112 trp1  his3-11,15 ura3-52 lys2 ssa1::HIS3 ssa3::TRP1
ssa1 ssa4 (MW329) MAT  leu2-3,112 trp1  his3-11,15 ura3-52 lys2 ssa1::HIS3 ssa4::LYS2
ssb1 ssb2 (JN212) Isogenic to JN54, ssb1-1::LEU2 ssb2-1::HIS31004 The Journal of Cell Biology | Volume 157, Number 6, 2002
dence for a protein mutator in yeast: role of the Hsp70-related chaperone ssb
in formation, stability, and toxicity of the [PSI] prion. Mol. Cell. Biol. 19:
8103–8112.
Cummings, C.J., H.T. Orr, and H.Y. Zoghbi. 1999a. Progress in pathogenesis
studies of spinocerebellar ataxia type 1. Philos. Trans. R. Soc. Lond. B Biol.
Sci. 354:1079–1081.
Cummings, C.J., E. Reinstein, Y. Sun, B. Antalffy, Y. Jiang, A. Ciechanover, H.T.
Orr, A.L. Beaudet, and H.Y. Zoghbi. 1999b. Mutation of the E6-AP ubiq-
uitin ligase reduces nuclear inclusion frequency while accelerating poly-
glutamine-induced pathology in SCA1 mice. Neuron. 24:879–892.
Davies, S.W., M. Turmaine, B.A. Cozens, M. Difiglia, A.H. Sharp, C.A. Ross, E.
Scherzinger, E.E. Wanker, L. Mangiarini, and G.P. Bates. 1997. Formation
of neuronal intranuclear inclusions underlies the neurological dysfunction in
mice transgenic for the Hd mutation. Cell. 90:537–548.
Davies, S.W., K. Beardsall, M. Turmaine, M. DiFiglia, N. Aronin, and G.P. Bates.
1998. Are neuronal intranuclear inclusions the common neuropathy of triplet-
repeat disorders with polyglutamine-repeat expansion? Lancet. 351:131–133.
Derkatch, I.L., M.E. Bradley, P. Zhou, Y.O. Chernoff, and S.W. Liebman. 1997.
Genetic and environmental factors affecting the de novo appearance of the
[PSI ] prion in Saccharomyces cerevisiae. Genetics. 147:507–519.
Derkatch, I.L., M.E. Bradley, J.Y. Hong, and S.W. Liebman. 2001. Prions affect
the appearance of other prions: the story of [PIN( )]. Cell. 106:171–182.
Difiglia, M., E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, J.P. Vonsattel, and N.
Aronin. 1997. Aggregation of huntingtin in neuronal intranuclear inclusions
and dystrophic neurites in brain. Science. 277:1990–1993.
Fabunmi, R.P., W.C. Wigley, P.J. Thomas, and G.N. DeMartino. 2000. Activity
and regulation of the centrosome-associated proteasome. J. Biol. Chem. 275:
409–413.
Garcia-Mata, R., Z. Bebok, E.J. Sorscher, and E.S. Sztul. 1999. Characterization
and dynamics of aggresome formation by a cytosolic GFP-chimera. J. Cell
Biol. 146:1239–1254.
Gusella, J.F., and M.E. Macdonald. 1998. Huntingtin—a single bait hooks many
species. Curr. Opin. Neurobiol. 8:425–430.
Hughes, R.E., R.S. Lo, C. Davis, A.D. Strand, C.L. Neal, J.M. Olson, and S.
Fields. 2001. Altered transcription in yeast expressing expanded poly-
glutamine. Proc. Natl. Acad. Sci. USA. 98:13201–13206.
Johnston, J.A., C.L. Ward, and R.R. Kopito. 1998. Aggresomes: a cellular response
to misfolded proteins. J. Cell Biol. 143:1883–1898.
Jung, G., G. Jones, R.D. Wegrzyn, and D.C. Masison. 2000. A role for cytosolic
hsp70 in yeast [PSI( )] prion propagation and [PSI( )] as a cellular stress.
Genetics. 156:559–570.
Kazantsev, A., E. Preisinger, A. Dranovsky, D. Goldgaber, and D. Housman.
1999. Insoluble detergent-resistant aggregates form between pathological
and nonpathological lengths of polyglutamine in mammalian cells. Proc.
Natl. Acad. Sci. USA. 96:11404–11409.
Kazemi-Esfarjani, P., and S. Benzer. 2000. Genetic suppression of polyglutamine
toxicity in Drosophila. Science. 287:1837–1840.
Klement, I.A., P.J. Skinner, M.D. Kaytor, H. Yi, S.M. Hersch, H.B. Clark, H.Y.
Zoghbi, and H.T. Orr. 1998. Ataxin-1 nuclear localization and aggregation: role
in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 95:41–53.
Krobitsch, S., and S. Lindquist. 2000. Aggregation of huntingtin in yeast varies
with the length of the polyglutamine expansion and the expression of chap-
erone proteins. Proc. Natl. Acad. Sci. USA. 97:1589–1594.
Meriin, A.B., K. Mabuchi, V.L. Gabai, J.A. Yaglom, A. Kazantsev, and M.Y. Sher-
man. 2001. Intracellular aggregation of polypeptides with expanded poly-
glutamine domain is stimulated by stress-activated kinase MEKK1. J. Cell
Biol. 153:851–864.
Moriyama, H., H.K. Edskes, and R.B. Wickner. 2000. [URE3] prion propagation
in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing
by overexpressed chaperone Ydj1p. Mol. Cell. Biol. 20:8916–8922.
Muchowski, P.J., G. Schaffar, A. Sittler, E.E. Wanker, M.K. Hayer-Hartl, and
F.U. Hartl. 2000. Hsp70 and hsp40 chaperones can inhibit self-assembly of
polyglutamine proteins into amyloid-like fibrils. Proc. Natl. Acad. Sci. USA.
97:7841–7846.
Newnam, G.P., R.D. Wegrzyn, S.L. Lindquist, and Y.O. Chernoff. 1999. Antago-
nistic interactions between yeast chaperones Hsp104 and Hsp70 in prion
curing. Mol. Cell. Biol. 19:1325–1333.
Patino, M.M., J.J. Liu, J.R. Glover, and S. Lindquist. 1996. Support for the prion
hypothesis for inheritance of a phenotypic trait in yeast. Science. 273:622–626.
Paushkin, S.V., V.V. Kushnirov, V.N. Smirnov, and M.D. Ter-Avanesyan. 1996.
Propagation of the yeast prion-like [psi ] determinant is mediated by oligo-
merization of the SUP35-encoded polypeptide chain release factor. EMBO J.
15:3127–3134.
Prusiner, S.B. 2001. Shattuck lecture—neurodegenerative diseases and prions. N.
Engl. J. Med. 344:1516–1526.
Satyal, S.H., E. Schmidt, K. Kitagawa, N. Sondheimer, S. Lindquist, J.M. Kramer,
and R.I. Morimoto. 2000. Polyglutamine aggregates alter protein folding ho-
meostasis in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 97:5750–5755.
Saudou, F., S. Finkbeiner, D. Devys, and M.E. Greenberg. 1998. Huntingtin acts
in the nucleus to induce apoptosis but death does not correlate with the for-
mation of intranuclear inclusions. Cell. 95:55–66.
Scherzinger, E., R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenbach, R. Hasen-
bank, G.P. Bates, S.W. Davies, H. Lehrach, and E.E. Wanker. 1997. Hun-
tingtin-encoded polyglutamine expansions form amyloid-like protein aggre-
gates in vitro and in vivo. Cell. 90:549–558.
Serio, T.R., and S.L. Lindquist. 2000. Protein-only inheritance in yeast: something
to get [PSI ]-ched about. Trends Cell Biol. 10:98–105.
Sherman, M.Y., and A.L. Goldberg. 2001. Cellular defenses against unfolded proteins:
a cell biologist thinks about neurodegenerative diseases. Neuron. 29:15–32.
Sondheimer, N., and S. Lindquist. 2000. Rnq1: an epigenetic modifier of protein
function in yeast. Mol. Cell. 5:163–172.
Sondheimer, N., N. Lopez, E.A. Craig, and S. Lindquist. 2001. The role of Sis1 in
the maintenance of the [RNQ ] prion. EMBO J. 20:2435–2442.
Stenoien, D.L., C.J. Cummings, H.P. Adams, M.G. Mancini, K. Patel, G.N. De-
Martino, M. Marcelli, N.L. Weigel, and M.A. Mancini. 1999. Poly-
glutamine-expanded androgen receptors form aggregates that sequester heat
shock proteins, proteasome components and SRC-1, and are suppressed by
the HDJ-2 chaperone. Hum. Mol. Genet. 8:731–741.
Vidair, C.A., R.N. Huang, and S.J. Doxsey. 1996. Heat shock causes protein ag-
gregation and reduced protein solubility at the centrosome and other cyto-
plasmic locations. Int. J. Hyperthermia. 12:681–695.
Waelter, S., A. Boeddrich, R. Lurz, E. Scherzinger, G. Lueder, H. Lehrach, and
E.E. Wanker. 2001. Accumulation of mutant huntingtin fragments in ag-
gresome-like inclusion bodies as a result of insufficient protein degradation.
Mol. Biol. Cell. 12:1393–1407.
Wegrzyn, R.D., K. Bapat, G.P. Newnam, A.D. Zink, and Y.O. Chernoff. 2001.
Mechanism of prion loss after Hsp104 inactivation in yeast. Mol. Cell. Biol.
21:4656–4669.
Wickner, R.B., H.K. Edskes, M.L. Maddelein, K.L. Taylor, and H. Moriyama.
1999. Prions of yeast and fungi. Proteins as genetic material. J. Biol. Chem.
274:555–558.
Wigley, W.C., R.P. Fabunmi, M.G. Lee, C.R. Marino, S. Muallem, G.N. DeMar-
tino, and P.J. Thomas. 1999. Dynamic association of proteasomal machin-
ery with the centrosome. J. Cell Biol. 145:481–490.
Winzeler, E.A., D.D. Shoemaker, A. Astromoff, H. Liang, K. Anderson, B. Andre,
R. Bangham, R. Benito, J.D. Boeke, H. Bussey, et al. 1999. Functional char-
acterization of the S. cerevisiae genome by gene deletion and parallel analysis.
Science. 285:901–906.
Wojcik, C., D. Schroeter, S. Wilk, J. Lamprecht, and N. Paweletz. 1996. Ubiq-
uitin-mediated proteolysis centers in HeLa cells—indication from studies of
an inhibitor of the chymotrypsin-like activity of the proteasome. Eur. J. Cell
Biol. 71:311–318.
Wyttenbach, A., J. Carmichael, J. Swartz, R.A. Furlong, Y. Narain, J. Rankin, and
D.C. Rubinsztein. 2000. Effects of heat shock, heat shock protein 40 (HDJ-
2), and proteasome inhibition on protein aggregation in cellular models of
Huntington’s disease. Proc. Natl. Acad. Sci. USA. 97:2898–2903.